Search results
Results from the WOW.Com Content Network
The IMHA was founded on June 17, 1997, during the 4th ISMH in Oslo, Norway chaired by Mohammed Saeme, who was also its first president. [1] [2] IMHA develops standards aim to improve the maritime health practices internationally, coordinating with national maritime authorities, the maritime industry, unions, and other international organizations.
Autoimmune hemolytic anemia: Anti-red blood cell antibodies Confirmed 1-3 per 100,000 [89] Immune thrombocytopenia: Anti-platelet antibodies Confirmed 3.3 per 100,000 (adults), 50 per 100,000 (children) [90] Thrombotic thrombocytopenic purpura: ADAMTS13 autoantibodies Confirmed 1-2 per million [91] Antiphospholipid syndrome: Antiphospholipid ...
Traumatic hemolytic anemia [2] Impact [2] Macrovascular defects-prostheses [2] Microvascular causes [2] Disseminated intravascular hemolysis [2] Thrombotic thrombocytopenic purpura [2] Typical and atypical hemolytic uremic syndrome [2] Other microvascular abnormalities; Hypersplenism [2] Hemolytic anemia due to toxic effects on the membrane ...
During this time, they report an overall health state drop – from 88% of patients falling between good and excellent, to 99% falling between good and very poor – and a decrease in health status index by more than half – from 3.8 (on a scale of 1 to 5) pre-illness, to 1.4 at diagnosis.
Mixed autoimmune hemolytic anemia (MAIHA) is a type of autoimmune hemolytic anemia which combines the features of cold sensitive antibody-induced diseases and warm autoimmune hemolytic anemia. The work-up for diagnosis is complex and the condition can be over-diagnosed. [1] [2] [better source needed] People diagnosed with warm autoimmune ...
Drug-induced autoimmune hemolytic anemia also known as Drug-induced immune hemolytic anemia (DIIHA) is a rare cause of hemolytic anemia.It is difficult to differentiate from other forms of anemia which can lead to delays in diagnosis and treatment.
Autoimmune hemolytic anemia: D59.0-D59.1: Autoimmune hemolytic anemia (AIHA) is a type of hemolytic anemia where the body's immune system attacks its own red blood cells (RBCs), leading to their destruction . [28] [29] Types of AIHA include warm autoimmune hemolytic anemia, cold agglutinin disease, and paroxysmal cold hemoglobinuria.
Related symptoms and signs include lethargy, decreased urine output, blood in the urine, kidney failure, low platelets, (which are needed for blood clotting), and destruction of red blood cells (microangiopathic hemolytic anemia).